146 participants
Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2017-04-06
- Start Date:
- 2005-02-28
- Completion:
- 2008-06-30
Conditions
- Hepatitis C, Chronic
Interventions
- BIOLOGICAL
- DRUG